Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

TransMedics Group, Inc. (TMDX)

$70.74 -1.83% NASDAQ: TMDX · 15-min delayed
  • ANDOVER, Massachusetts
  • Public · NASDAQ: TMDX
  • 898 employees
$2.5BMarket cap
$605.5MRevenue · FY2025
$190.3MNet income
898Employees
TMDXNASDAQ
2019IPO

About TransMedics Group, Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$605.5M
Net income
$190.3M
Total assets
$1.1B
Market cap
$2.5B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: TMDX
$70.74 -1.83%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$62.04 $150.42

52-week range

Market cap
$2.5B
Shares outstanding
35.3M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
May 2, 2019

TransMedics Group, Inc. (TMDX) Stock Price

  • Profitable — net income of $190.3M in FY2025.
  • Trading 53% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review TransMedics Group, Inc..

Write a review
Newsroom

News about TransMedics Group, Inc.

News & sentiment via Polygon.io

FAQ

TransMedics Group, Inc.: frequently asked questions

Is TransMedics Group, Inc. an American company?

TransMedics Group, Inc. is a US-based company headquartered in Andover, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is TransMedics Group, Inc. headquartered?

TransMedics Group, Inc. is headquartered in Andover, Massachusetts, United States.

Is TransMedics Group, Inc. publicly traded?

Yes — TransMedics Group, Inc. is a publicly traded company. Its stock trades under the ticker symbol TMDX on the NASDAQ.

What does TransMedics Group, Inc. do?

TransMedics Group, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →